| Financial Year |
March 31 2023 |
| Monetary Funds |
980,139,458.01 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,151,858.00 |
| Accounts Receivable |
548,416,147.54 |
| Advances to Suppliers |
154,288,871.49 |
| Other Receivables |
80,816,608.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,462,253,388.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,085,734.98 |
| Total Current Assets |
4,402,406,363.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,035,855.66 |
| Investment Properties |
8,020,954.96 |
| Fixed Assetes |
788,301,910.86 |
| Under-construction Projects |
330,801,644.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
412,469,242.62 |
| R&D expenses |
-- |
| Goodwill |
206,680,494.59 |
| Long-Term Deferred and Prepaid Expenses |
6,487,756.91 |
| Deferred Income Tax Assets |
17,887,217.54 |
| Other Non-Current Assets |
33,418,961.95 |
| Sub-Total of Non-Current Assets |
2,181,668,233.05 |
| Total Assets |
6,584,074,596.89 |
| Short-Term Loans |
437,263,210.54 |
| Trading Financial liabilities |
53,067.50 |
| Notes Payable |
336,967,454.95 |
| Accounts Payable |
463,829,127.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
45,662,340.60 |
| Taxes Payable |
26,267,748.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,516,269.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,824,084.16 |
| Other Current Liabilities |
66,042,271.59 |
| Sub-Total of Current Liabilities |
2,555,352,371.01 |
| Long-term Loans |
769,448,388.64 |
| Bonds Payable |
471,214,971.33 |
| Long-Term Accounts Payable |
7,362,506.91 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,772,794.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,312,135,767.01 |
| Total Liabilities |
3,867,488,138.02 |
| Paid-In Capital(Or Share Stock) |
488,164,280.00 |
| Capital Surplus |
922,588,373.06 |
| Surplus Reserve |
122,951,212.08 |
| LESS:Treasury Stock |
56,728,478.98 |
| Undistributed Profits |
995,086,089.92 |
| Minority Stockholder's Interest |
96,550,447.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,620,036,011.30 |
| Owner's Equity（Stockholder's Equity） |
2,716,586,458.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,584,074,596.89 |
